<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03999047</url>
  </required_header>
  <id_info>
    <org_study_id>REG-070-2017</org_study_id>
    <secondary_id>707462</secondary_id>
    <nct_id>NCT03999047</nct_id>
  </id_info>
  <brief_title>Validation of the Screening Instrument: PRISMA-7 for Frailty Among Elderly Hospitalized Danes</brief_title>
  <official_title>Validation of the Screening Instrument: PRISMA-7 for Frailty Among +75 Year Old Danes Still in Need of Physical Training When They Are Sent Home After a Hospital Stay</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Zealand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Southern Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Region Zealand</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The questionnaire PRISMA-7 was originally developed to assess frailty in community dwelling
      adults. The questionnaire was translated into the Danish language. This instrument was used
      to screen for frailty among elderly patients (75+) sent home from Nykøbing Falster Hospital
      after a hospital admission during the period 31. May 2017 until December 31st, 2018. PRISMA
      results were used to categorize each individula as frail or non-frail. The register of PRISMA
      results was merged with national registers on use of health serviced in order to investigate
      if increasing PRISMA score was associated with increasing use of health services.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data from PRISMA scores were registered in an EasyTrial database. This database is recognized
      by the regional health authorities as a safe system to store individual health data. All use
      of the EasyTRial database is logged. The merging of data from the local EasyTRial database
      with data from national registries on use of health services and on mortality was permitted
      by the Danish National Health Data protection authorities.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 16, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>6 months after PRISMA-7 screening</time_frame>
    <description>Mortality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Morbidity</measure>
    <time_frame>6 months after Prisma-7 screening</time_frame>
    <description>Morbidity will be measured by registering Hospital admissions and use of general practitioner</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Use of other health services</measure>
    <time_frame>6 months before PRISMA-7 screening</time_frame>
    <description>Home help, rehabilitation services in the municipality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>6 months after PRISMA-7 screening</time_frame>
    <description>Morbidity will be measured by registering hospital admissions and use og general practitioner</description>
  </secondary_outcome>
  <enrollment type="Actual">1050</enrollment>
  <condition>Frailty Syndrome</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>PRISMA score</intervention_name>
    <description>Screening for frailty using PRISMA-7</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Persons 75 years old og older who have been staying in hospital and are in need physical
        rehabilitation in the municipality when they are sent home from hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  75 years old persons being returned from hospital after a hospital admission and in
             need of further physical rehabilitation in the community

        Exclusion Criteria:

        Not able to give informed consent or if necessary not having a relative that can give
        informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ellen A Holm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Region Sjælland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nykøbing Falster Hospital</name>
      <address>
        <city>Nykøbing Falster</city>
        <zip>4800</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Turner G, Clegg A; British Geriatrics Society; Age UK; Royal College of General Practioners. Best practice guidelines for the management of frailty: a British Geriatrics Society, Age UK and Royal College of General Practitioners report. Age Ageing. 2014 Nov;43(6):744-7. doi: 10.1093/ageing/afu138. Review.</citation>
    <PMID>25336440</PMID>
  </reference>
  <reference>
    <citation>Hébert R, Durand PJ, Dubuc N, Tourigny A; PRISMA Group. Frail elderly patients. New model for integrated service delivery. Can Fam Physician. 2003 Aug;49:992-7.</citation>
    <PMID>12943358</PMID>
  </reference>
  <reference>
    <citation>Raîche M, Hébert R, Dubois MF. PRISMA-7: a case-finding tool to identify older adults with moderate to severe disabilities. Arch Gerontol Geriatr. 2008 Jul-Aug;47(1):9-18. Epub 2007 Aug 27.</citation>
    <PMID>17723247</PMID>
  </reference>
  <reference>
    <citation>Braun T, Grüneberg C, Thiel C. German translation, cross-cultural adaptation and diagnostic test accuracy of three frailty screening tools : PRISMA-7, FRAIL scale and Groningen Frailty Indicator. Z Gerontol Geriatr. 2018 Apr;51(3):282-292. doi: 10.1007/s00391-017-1295-2. Epub 2017 Aug 9.</citation>
    <PMID>28795247</PMID>
  </reference>
  <reference>
    <citation>Hoogendijk EO, van der Horst HE, Deeg DJ, Frijters DH, Prins BA, Jansen AP, Nijpels G, van Hout HP. The identification of frail older adults in primary care: comparing the accuracy of five simple instruments. Age Ageing. 2013 Mar;42(2):262-5. doi: 10.1093/ageing/afs163. Epub 2012 Oct 28.</citation>
    <PMID>23108163</PMID>
  </reference>
  <reference>
    <citation>Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011 Jul;39(7 Suppl):30-3. doi: 10.1177/1403494811401482.</citation>
    <PMID>21775347</PMID>
  </reference>
  <reference>
    <citation>Andersen JS, Olivarius Nde F, Krasnik A. The Danish National Health Service Register. Scand J Public Health. 2011 Jul;39(7 Suppl):34-7. doi: 10.1177/1403494810394718.</citation>
    <PMID>21775348</PMID>
  </reference>
  <reference>
    <citation>Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011 Jul;39(7 Suppl):38-41. doi: 10.1177/1403494810394717.</citation>
    <PMID>21775349</PMID>
  </reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 16, 2019</study_first_submitted>
  <study_first_submitted_qc>June 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2019</study_first_posted>
  <last_update_submitted>June 24, 2019</last_update_submitted>
  <last_update_submitted_qc>June 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Region Zealand</investigator_affiliation>
    <investigator_full_name>Ellen Holm</investigator_full_name>
    <investigator_title>Consultant</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Frailty</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 20, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/47/NCT03999047/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

